CSIMarket
 


In Vitro & In Vivo Diagnostic Substances Industry

Cash-Flow Margins, Effective Tax Rates Information & Trends 
  

Effective Tax Rate Statistics

 

Effective Tax Rate Comment
In Vitro & In Vivo Diagnostic Substances Industry recorded pre-tax loss in 1 Q .



Within Healthcare sector 3 other industries had lower effective tax rate. Effective tax rate total ranking has deteriorated compare to previous quarter from to 38.


Effective Tax Rate Statistics
High Average Low
235.84 % -809.01 % -10539.51 %
2. quarter 2022   4. quarter 2021


Effective Tax Rate Industry Ranking
Within: No.
Healthcare Sector # 4
Overall # 38

Effective Tax Rate Statistics

 
Effective Tax Rate Comment
In Vitro & In Vivo Diagnostic Substances Industry recorded pre-tax loss in 1 Q .



Within Healthcare sector 3 other industries had lower effective tax rate. Effective tax rate total ranking has deteriorated compare to previous quarter from to 38.

Effective Tax Rate Statistics
High Average Low
235.84 % -809.01 % -10539.51 %
2. quarter 2022   4. quarter 2021
Effective Tax Rate Industry Ranking
Within: No.
Healthcare Sector # 4
Overall # 38

Category:   Period:  

In Vitro & In Vivo Diagnostic Substances Industry 1 Q 4 Q 3 Q 2 Q 1 Q
  2024 2023 2023 2023 2023
Free Cash Flow Margin 11.15 % 16.55 % 11.4 % 4.11 % 9.67 %
Free Cash Flow Margin (TTM) 18.93 % 21.58 % 17.85 % 16.44 % 16.98 %
Free Cash Flow Margin Ranking # 15 # 1 # 17 # 95 # 64
Net Cash Flow Margin - 19.42 % 13.67 % - -
Net Cash Flow Margin (TTM) 4.97 % 12.38 % 6.64 % 2.72 % -
Net Cash Flow Margin Ranking # 15 # 1 # 17 # 95 # 64
Effective Tax Rate - 31.53 % 51.18 % 170.94 % 48.56 %
Effective Tax Rate (TTM) - 31.13 % 153.19 % 211.52 % 138.15 %
Effective Tax Rate Ranking # 38 # 31 # 23 # 4 # 90


Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.

Free Cash Flow Margin Comment

In Vitro & In Vivo Diagnostic Substances Industry's Free Cash Flow Margin sequentially deteriorated to 11.15 % due to decline in Free Cash Flow and despite Revenue increase of 5.08 %.
In Vitro & In Vivo Diagnostic Substances Industry's Free Cash Flow Margin in 1 Q was higher than Industry average.

On the trailing twelve months basis Free Cash Flow Margin in 1 Q fell to 18.93 %.

Within Healthcare sector, In Vitro & In Vivo Diagnostic Substances Industry achieved highest Free Cash Flow Margin. Free Cash Flow Margin total ranking has deteriorated compare to previous quarter from to 15.
Free Cash Flow Margin Statistics
High Average Low
94.99 % -545.47 % -5419.13 %
4. quarter 2020   4. quarter 2021

Free Cash Flow Margin Industry Ranking
Within: No.
Healthcare Sector # 1
Overall # 15




Other Gross Margins
Compare Industry's gross margin to 's or S&P Gross profits within In Vitro & In Vivo Diagnostic Substances Industry
Highest Ranking Gross Margins Lowest Ranking Gross Margins
Profitability for Industry's Suppliers Definiton of Gross Margin

Net Cash Flow Margin Statistics

 


Net Cash Flow Margin Industry Ranking
Within: No.
Healthcare Sector # 6
Overall # 68

Net Cash Flow Margin Statistics
High Average Low
104.6 % -388.12 % -5849.98 %
4. quarter 2020   4. quarter 2021

Net Cash Flow Margin Comment
In Vitro & In Vivo Diagnostic Substances Industry recorded net cash spending compare to Net Cash Flow achieved in previous quarter.

On the trailing twelve months basis Net Cash Flow Margin in 1 Q fell to 4.97 %.

Within Healthcare sector 5 other industries have achieved higher Net Cash Flow Margin. Net Cash Flow Margin total ranking has deteriorated compare to previous quarter from to 68.

Net Cash Flow Margin Statistics

 
Net Cash Flow Margin Industry Ranking
Within: No.
Healthcare Sector # 6
Overall # 68
Net Cash Flow Margin Statistics
High Average Low
104.6 % -388.12 % -5849.98 %
4. quarter 2020   4. quarter 2021

Net Cash Flow Margin Comment
In Vitro & In Vivo Diagnostic Substances Industry recorded net cash spending compare to Net Cash Flow achieved in previous quarter.

On the trailing twelve months basis Net Cash Flow Margin in 1 Q fell to 4.97 %.

Within Healthcare sector 5 other industries have achieved higher Net Cash Flow Margin. Net Cash Flow Margin total ranking has deteriorated compare to previous quarter from to 68.


Other Links Margins
Compare Industry's Effective Tax Rate to 's or S&P Pre-Tax Margin within In Vitro & In Vivo Diagnostic Substances Industry
Definiton of Effective Tax Rate



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com